Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine dose comparison for postoperative gastrointestinal recovery after laparoscopic surgery for uterine fibroids
ChiCTR2300074452Phase 4Recruiting
- Sponsor
- Second Hospital of Lanzhou University
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in Fibromyoma (LM) (3 arms), sponsored by Second Hospital of Lanzhou University. Primary endpoints: I-FABP, claudin-1 and 2 more. Started May 2023; status: recruiting.
02
Drugs
esketamine
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ChiCTR2300074452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074452.